04/25/2024
4:30 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024
8:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
7:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/29/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
7:17 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024
3:30 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
02/29/2024
6:35 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:32 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2024
8:09 AM | Evaxion Biotech A/S (Filer)
| Form 424B4 | |
02/05/2024
6:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/01/2024
11:15 PM | Evaxion Biotech A/S (Filer)
| Form EFFECT | |
02/01/2024
8:20 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024
4:10 PM | Evaxion Biotech A/S (Filer)
| Form F-1/A | |
01/31/2024
8:26 AM | Evaxion Biotech A/S (Filer)
| Form F-1/A | |
01/30/2024
2:16 PM | Evaxion Biotech A/S (Filer)
| Form F-1/A | |
01/23/2024
2:29 PM | Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
| Form SC 13G | |
01/22/2024
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/12/2024
4:17 PM | Evaxion Biotech A/S (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
01/12/2024
8:24 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2024
7:44 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/21/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2023
7:45 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/28/2023
7:27 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/17/2023
8:15 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2023
7:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/06/2023
9:12 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2023
10:22 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/26/2023
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/13/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/05/2023
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 424B4 | |
09/11/2023
7:17 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/07/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K/A | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
08/30/2023
11:15 PM | Evaxion Biotech A/S (Filer)
| Form EFFECT | |
08/29/2023
8:22 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/25/2023
4:00 PM | Evaxion Biotech A/S (Filer)
| Form POS AM | |
08/18/2023
8:28 AM | Evaxion Biotech A/S (Filer)
| Form 6-K/A | |
08/17/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/04/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023
6:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023
6:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2023
8:14 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2023
7:32 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2023
6:44 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2023
7:36 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
